Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Chembio Diagnostics revenue
Chembio Diagnostics's revenue is $49.5 billion.
What is Chembio Diagnostics's revenue?
- Chembio Diagnostics's revenue growth from 2004 to 2022 is 1,397.97%.
- Chembio Diagnostics has 355 employees, and the revenue per employee ratio is $139,498,374.
- Chembio Diagnostics's peak quarterly revenue was $49.5B in 2022(q4).
- Chembio Diagnostics peak revenue was $49.5B in 2022.
- Chembio Diagnostics annual revenue for 2021 was 47.8B, 47.27% growth from 2020.
- Chembio Diagnostics annual revenue for 2022 was 49.5B, 3.56% growth from 2021.
On this page
Zippi applies for you, and finds you a job.
Chembio Diagnostics historical revenue
Chembio Diagnostics's peak revenue was $49.5B in 2022. The peak quarterly revenue was $49.5B in 2022(q4).
Chembio Diagnostics's revenue increased from $3.3m in 2004 to $49.5B currently. That's a 1,397.97% change in annual revenue.
Chembio Diagnostics annual revenue
Chembio Diagnostics annual revenue over time
| Fiscal year / year | Chembio Diagnostics revenue |
|---|---|
| 2009 | $13.8B |
| 2010 | $16.7B |
| 2011 | $19.4B |
| 2012 | $25.6B |
| 2013 | $29.5B |
| 2014 | $27.6B |
| 2015 | $24.3B |
| 2016 | $17.9B |
| 2017 | $24.0B |
| 2018 | $34.6B |
| 2019 | $34.5B |
| 2020 | $32.5B |
| 2021 | $47.8B |
| 2022 | $49.5B |
How accurately did Chembio Diagnostics' revenue projections match actual performance?
Chembio Diagnostics annual growth
Chembio Diagnostics saw the greatest revenue growth in 2021, when revenue increased by 147,168.75%.
Chembio Diagnostics had the lowest revenue growth in 2016, when revenue changed by -26.33%.
Chembio Diagnostics annual growth rate over time
| Year | Chembio Diagnostics growth |
|---|---|
| 2009 | 25%↑ |
| 2010 | 21%↑ |
| 2011 | 16%↑ |
| 2012 | 32%↑ |
| 2013 | 15%↑ |
| 2014 | -6%↓ |
| 2015 | -12%↓ |
| 2016 | -26%↓ |
| 2017 | 34%↑ |
| 2018 | 44%↑ |
| 2019 | -0%↓ |
| 2020 | -6%↓ |
| 2021 | 47%↑ |
| 2022 | 4%↑ |
Chembio Diagnostics jobs nearby
Do you work at Chembio Diagnostics?
Is Chembio Diagnostics transparent about its revenue structure?
Chembio Diagnostics financial information
| CEO | Richard L. Eberly |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 355 |
| Date Founded | 1986 |
| Headquarters | Medford, New York |
| Number of Locations | 2 |
| Revenue | $49.5B |
| Net Income | -$23,290,657,000 |
| Gross Proft | $10.9B (2022) |
| PE Ratio | -0.00 |
| Tax Rate | -0.0% |
| Market Capitalization | $92.8M |
| Total Assets | $62,611,405,000 |
| Ticker | CEMI |
Chembio Diagnostics jobs you might like
Chembio Diagnostics competitors
Chembio Diagnostics's top competitor, Cepheid, earned an annual revenue of $531.1M.
Chembio Diagnostics's smallest competitor is IRX Therapeutics with revenue of $1.4M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| BioLife Solutions | $46,964 | $119.2M | 54 | 662 |
| Opti Medical Systems | $62,971 | $27.3M | 105 | - |
| CIMA Labs | $74,201 | $8.5M | 120 | 15 |
| TECHLAB, Inc. | $46,450 | $25.0M | 100 | - |
| Rapid Micro Biosystems | $68,093 | $28.1M | 158 | 6 |
| Focus Diagnostics | $58,992 | $19.0M | 350 | - |
| Cepheid | $86,295 | $531.1M | 6,000 | 6 |
| KBI Biopharma Inc. | $54,344 | $62.3M | 6 | 86 |
| IRX Therapeutics | $48,347 | $1.4M | 18 | - |
| Humacyte | $50,542 | $1.6M | 130 | 8 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Chembio Diagnostics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Chembio Diagnostics. The employee data is based on information from people who have self-reported their past or current employments at Chembio Diagnostics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Chembio Diagnostics. The data presented on this page does not represent the view of Chembio Diagnostics and its employees or that of Zippia.
Chembio Diagnostics may also be known as or be related to Chembio Diagnostic Systems Inc, Chembio Diagnostic Systems Inc., Chembio Diagnostic Systems, Inc., Chembio Diagnostics, Chembio Diagnostics Inc, Chembio Diagnostics Inc. and Chembio Diagnostics, Inc.